Mibavademab | Interleukin Related interleukin-related.com

Product Name :
Mibavademab

Search keywords :
Leptin Receptor

drugId :
null

Target Vo:
Leptin receptor

Target Vo Short Name :
LEPR

Moa_Name:
Leptin receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Regeneron Pharmaceuticals Inc

Active Company_Name :
Eli Lilly And Company

Active Indication_Name:
Obesity

In Active Indication_Name:
Lipodystrophy, Familial Partial

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Nemolizumab site
Sintilimab PD-1/PD-L1
APOA1 Antibody: APOA1 Antibody is an unconjugated, approximately 28 kDa, rabbit-derived, anti-APOA1 polyclonal antibody. APOA1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, chicken, and predicted: pig, cow background without labeling.

Author: Interleukin Related

Related Posts